Cardiovascular CRO Experts
A Cardiovascular CRO is a clinical research organization that conducts studies in the cardiovascular system. These companies specialize in the development of clinical trials that will ultimately benefit patients. Vial was find by a group of pioneering interventional cardiologists. Their landmark study comparing immediate coronary angioplasty to intravenous streptokinase for acute myocardial infarction set a new standard for treatment.
Originally, Vial CRO was form as a Site Management Organization (SMO) to support local clinical trials and soon expand into a CRO. Cardiovascular CRO provide an array of services to sponsors of clinical trials. A few of these providers include PhysioStim, George Clinical, and Vial CRO. Each offers different types of services, so it’s important to select the one best suit to your needs.
Vial CRO
If you’re planning to start a cardiovascular clinical trial, you need an experienced, specialize CRO. The Vial Cardiovascular CRO team combines a wealth of experience with cutting-edge data and analytics, making it the ideal partner for any cardiovascular study. Whether you’re designing a large study or a small study, Vial CRO offers a range of services that ensure a successful outcome.
The company’s mission is to help clients achieve their goals. They do this by providing advanced analytics, clinical research services and technology solutions. In addition, Vial CRO team of clinical experts helps clients accelerate their clinical development with prove methodologies. Vial CRO is one of the largest CROs in the world, operating in over 100 countries.
Vial CRO is a global clinical research organization (CRO) with more than 88,000 employees worldwide. It was find in North Carolina in 1982 and has grow to encompass more than a dozen countries. Its parent company, Parexel, operates in more than 50 countries and employs more than 18,000 people globally.
Vial CRO is recognize as the leading global provider of advanced analytics and technology solutions. It was name the top CRO in overall reputation by clinical research sites in the 2021 WCG CenterWatch Global Site Relationship Benchmark Survey. The company aims to improve patient outcomes by improving healthcare access and delivery.
PhysioStim
PhysioStim is an independent preclinical CRO with specialize knowledge in cardiovascular electro-physiology and pharmacology. Founded in 2000, the CRO is headquarter in Lautrec, Southern France. The firm was establish to address the growing demand for high-quality cardiovascular research. Today, it has become a trust team for clients looking for clinical trials in cardiovascular pharmacology. It provides services across the entire drug discovery process, from discovery to post-market analysis.
The company also conducts cardiac safety studies on pharmaceutical compounds and biologics. Its services are focus on ensuring that the safety and efficacy of cardiovascular therapeutics are assess in human volunteers. PhysioStim utilizes the xCELLigence RTCA CardioECR system and human induced pluripotent stem cells to assess cardiovascular toxicity.
George Clinical
George Clinical, a global clinical research organization, focuses on improving patient lives around the globe. The company operates in the US, Asia, Europe, and Australia, and provides comprehensive clinical trial services. Its therapeutic areas include cardiovascular disease, oncology, and respiratory disease. George Clinical offers a variety of services to meet the needs of researchers and sponsors.
Link Health, a leading Chinese pharmaceutical company, and George Clinical are please to announce a joint venture partnership. The new partnership will develop and deliver clinical trials for Link Health and other related companies. The companies plan to launch six trials in 2021. The collaboration willcontinue to expand as Link Health’s portfolio grows.
In Asia-Pacific
George Clinical is one of the leading cardiovascular CROs. The company works closely with its regional partners in the region, including the Cardio Union, to build investigator networks of the highest quality. The company also maintains close relationships with Taiwan’s National Institute of Health and Welfare. This unique collaboration allows researchers to access highly qualified investigator networks that are experienced in cardiovascular research.
George Clinical has an established presence in the Philippines, where it plans to formalize collaborations and conduct clinical trials. The country has a population of treatment naive patients, which makes it a prime location for conducting trials of cardiovascular drugs. Furthermore, George Clinical is expanding its global operations, with offices in the US and the United Kingdom. This expansion will allow the company to better serve its clients and improve the quality of trials.
Cardialysis
Cardiovascular CROs focus exclusively on the cardiovascular field and offer a full range of clinical research and cardiovascular core laboratory services. Founded in 1983, Cardialysis has grown to become a world-class cardiovascular CRO, with extensive experience in cardiovascular research. The company has a strong academic and key opinion leader network and is recognized for its full-service clinical operations. It has partnered with leading medical device and biotechnology companies to complete more than 400 clinical trials.
A number of cardiovascular CROs provide services related to cardiac imaging. One such CRO is GRS, which selects MedStar, an internationally recognized cardiac imaging corelab, to perform all of its studies in the cardiovascular field. The firm’s comprehensive services and expertise in cardiac imaging enable it to efficiently manage clinical trials.
A cardiovascular CRO is vital to the success of a clinical study, so it is critical to find a provider with extensive experience and a proven track record. Vial CRO is a leading cardiovascular CRO with extensive experience and innovative approaches based on analytics and data. This specialized research organization can successfully handle cardiovascular trials of any size, and its agility is unmatched.
Karen Hill
Karen Hill, Cardiovascular CRO, has more than 25 years of experience in the pharmaceutical industry. Her responsibilities include providing project management and supervision to clinical research associates (CRAs). She also oversees global teams that conduct large cardiovascular outcome studies and trials for cardiovascular and metabolic diseases. She specializes in cardiovascular trials, including phase II-IV clinical trials.
In addition to her roles as CEO and president of GNS Healthcare, Hill has contributed to the nursing community in numerous ways. She is currently Editor-in-Chief of the Journal of Nursing Administration, a peer-reviewed international journal, and has authored more than 65 publications. She is also the co-author of a book on creating a research environment in community hospitals. Hill has presented internationally on topics such as bringing evidence to practice, managing a diverse workforce, and retaining experienced, older employees.
In addition to her professional life, Karen Hill is an active member of the local community. She is chair-elect of the Lexington-Carolina Chamber of Commerce, chair of the Hospital Advisory Commission for The Joint Commission, and is an active supporter of numerous local health-related charities. She also serves as an usher at her church.
Read also: What is a CRO – Contract Research Organization?
Dr. Huffman is an emerging leader in health and medicine scholar
As an assistant professor of medicine-cardiology and preventive medicine, Dr. Huffman is focused on global cardiovascular epidemiology. He leads a clinical trial in Kerala, India, on improving treatment and prevention of acute coronary syndromes. He also serves as the coordinating editor of the Cochrane Heart Group US satellite. In addition, he has been a member of the American Heart Association Institute for Precision Cardiovascular Medicine Task Force and an expert reviewer of the Global Burden of Disease project.
In addition to her work, Dr. Huffman is also an accomplished human rights researcher. She is one of 10 ELHM Scholars selected this year. The program was launched in 2016, and selects early and mid-career health professionals for mentoring and collaboration opportunities that can advance their careers.
As a fellow in the Emerging Leaders program, she will participate in the NAM Emerging Leaders Forum in Washington, D.C., where she will participate in a collaborative environment and contribute to shaping NAM priorities. During the forum, she will also be invited to discuss innovative solutions to urgent medical challenges. As an Emerging Leader in Health and Medicine scholar, she is actively engaged in multidisciplinary research and is an advocate for health equity.
Dr. Rodgers is an emerging leader in health and medicine scholar
A graduate of Brown University, Dr. Rodgers received his undergraduate and graduate degrees, as well as his medical degree. He has also been recognized with named lectureships at leading medical centers throughout the country. He has authored more than 250 research articles and four books and monographs, and he holds three patents. His academic background has earned him numerous awards, including election to the American Academy of Arts and Sciences, the Royal College of Physicians, and the American Academy of Arts and Sciences.
In addition to leading the NIH, Dr. Rodgers serves on numerous advisory boards. Dr. Rodgers chairs the NIH’s Obesity and Nutrition Research Task Force, and serves on the Executive Committee of the Accelerating Medicines Partnership. Dr. Rodgers also co-leads the NIH Common Fund’s Illuminating the Druggable Genome initiative. He also serves on the NIH-FDA Joint Leadership Council and the NIH-FDA Steering Committee.
In addition to her scientific career
Dr. Rodgers’ laboratory focuses on multidisciplinary approaches to address complex health issues. Her lab employs an interdisciplinary approach to develop new methods to improve the health of people of all backgrounds. He is also a National Academy of Medicine Fellow.
Her research agenda focuses on improving colorectal cancer awareness among African-American men. She also has interests in cancer health disparities, behavioral & community-based interventions, mixed methods, and survey methodology. Several awards and scholarships recognize her unique abilities and commitment to diversity and equity.
As an Emerging Leader in Health and Medicine Scholar, Dr. Rogers is collaborating with the National Academy of Medicine to tackle some of the most pressing challenges in health and medicine. She is also a visiting faculty member at the Institute for Clinical and Transnational Research at Columbia University Irving Medical Center.
Professor Rodgers is an emerging leader in health care and medicine scholar with a focus on public-private partnerships and the development of affordable medicines. She was one of the lead authors of the 2002 World Health Report and has led a public-private partnership to develop an affordable four-in-one cardiovascular combination pill. In addition, her current work focuses on fostering fit-for-purpose development in low-income settings.
In addition to her research, she has received many awards and fellowships. She holds a PhD in economics and a Postdoctoral Certificate in health services research. She has published more than 80 peer-reviewed journal articles and government reports and has also authored two books.
Dr. Sundstrom is an emerging leader in health and medicine
Dr. Sundstrom has an impressive resume and is an expert in health communications. She holds a Ph.D. in Communication from the University of Maryland College Park, where she specialized in health communication and public relations. She also earned a Master of Public Health from Brown University, where she focused on women’s health. Her undergraduate degree is in political science from Tulane University.
As an undergraduate, Dr. Sundstrom attended Maclay High School in Tallahassee, Florida. While in medical school, she served as vice president of the Medical College Council and was awarded the Golden Caduceus award for her outstanding contributions to medical students. A lifelong reader, Dr. Sundstrom’s work has been cited in international guidelines on cardiovascular disease prevention.
Currently, she serves as director of the Women’s Health Research Team at the University of Charleston. She is also a faculty affiliate in the School of Public Health’s Women’s and Gender Studies program. She is also a member of the Executive Committee for Cervical Cancer-Free South Carolina, the Charleston County Teen Pregnancy Prevention Council, and the South Carolina Cervical Cancer Awareness Initiative.
In addition to her professional work
She has honor with many awards, including the William V. Moore Distinguish Teacher-Scholar Award at the College of Charleston and the ExCEL Award as Outstanding Faculty of the Year. In addition, she was name one of Charleston’s 50 Most Progressive Individuals.
As an emerging leader in health and medicine, Dr. Sundstrom has been recognize by the National Academy of Medicine (NAM). She is the first women to be name to the Academy since 2016. As a scholar of the program, she will receive mentoring, collaboration, and innovation opportunities.
Sundstrom, B., is a researcher and a communication expert. Her publications focus on health communication and mass media, and she also breaks taboos about women’s health and gender. Her work integrates social marketing theory with diffusion of innovations theory. She has collaborated with Briones, R.L., and Bates to write a textbook on health communication and mass media.